NCT03073798View on ClinicalTrials.gov

The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 18, 2013

Primary Completion Date

May 14, 2015

Study Completion Date

May 14, 2015

Conditions
COPDChronic BronchitisEmphysema
Interventions
DRUG

Roflumilast

500 mcg of Roflumilast which is a prescription medicine used in adults with severe COPD to decrease the number of flare-ups or the worsening of COPD symptoms

DRUG

Placebo

500 mcg of placebo is used

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03073798 - The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis | Biotech Hunter | Biotech Hunter